PEOPLE > Adeera Levin, M.D., F.R.C.P.C

Adeera Levin, M.D., F.R.C.P.C

Head, Division of Nephrology, University of British Columbia; Executive Director, BC Provincial Renal Agency

Education and Training

Research Interests

Dr. Levin is a Professor of Medicine, Head of the Division of Nephrology at the University of British Columbia, and Consultant nephrologist at Providence Health Care/St Paul’s Hospital, in Vancouver, Canada.

She is the Executive Director of the BC Renal Agency which oversees the care, planning and budgets for kidney services in the province of British Columbia. In this capacity, she has leveraged her epidemiological training, clinical knowledge and health outcomes research to develop an evidence-based transparent system which enhances the care of patients across the continuum of care (from identification of CKD through to dialysis, transplant and death).

She is active in international activities across the spectrum of kidney activities, and has served as Secretary General of the International Society of Nephrology (ISN), and is now President Elect of ISN.

Her major research areas of interest include non traditional risk factors for CVD in CKD patients (with particular focus on anemia, phosphate and vitamin D, and progression of CKD variability) as well as models of care. She has 268 peer reviewed publications, numerous book chapters, and is co-editor of a textbook “Chronic Kidney Disease: a practical guide to understanding and management.”

She has received numerous teaching and research awards from local and national groups. In 2013, she was awarded the Canadian Society of Nephrology Outstanding Contributions to Canadian Nephrology and in 2014, the Kidney Foundation of Canada Research medal of Excellence. She was also awarded a fellowship of the Canadian Academy of Health Sciences. She has recently been honored with the National Kidney Foundation’s International Distinguished Medal for 2015 which recognizes the achievement of individuals who have made a significant contribution to the field of kidney disease.

She serves on numerous editorial boards and reviews for major kidney and medicine journals. She is the inaugural Editor-in-Chief of the new Canadian Journal of Kidney Health & Disease. She is the Principal Investigator on a large cohort study CAN-PREDDICT, and holds numerous peer reviewed grants. She collaborates with investigators across Canada and internationally.

SELECTED PUBLICATIONS

View Publications on PubMed

Levin A, Commentary on “Kidney disease guideline profusion and confusion: unintended consequences of different perspectives and definitions”, AJKD, May 2014; Vol 63, Issue 5, pp 749-52

Levin A, Lo C, Noel K, Djurdjev O, Amano E, “Activity-based funding model provides foundation for province-wide best practices in renal care”, Healthcare Quarterly, Oct 2013; 16:4, pp 49-54

Levin A, Rigatto C, Barrett B, Madore F, Muirhead N, Clase C, Tang M, Djurdjev O, and on behalf of the CanPREDDICT Investigators, “Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort”, NDT, May 2014; 29(5), pp 1035-45

Levin A, Stevens PE, “Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward”, KI, Jan 2014; 85(1), pp 49-61

Eckhardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, Levin A, “The evolving importance of kidney disease – from a subspecialty focus to a global health burden”, The Lancet, Jul 2013; Vol 382, No 9887, pp 158-69

Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal S, Kimm H, Kronenberg F, Oien C, Levey A, Levin A, Woodward M, Hemmelgarn B, for the Chronic Kidney Disease Prognosis Consortium, “Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis”, BMJ, Jan 2013; 346:f324